Essential Pharma acquires Reminyl from Janssen Pharmaceutica
Pharmaceutical Technology
APRIL 18, 2024
Essential Pharma has concluded the acquisition of Reminyl oral capsules from Johnson & Johnson company Janssen Pharmaceutica.
pharma 
How can pharma speed time to treatment? Digital tools can help
Bio Pharma Dive
APRIL 22, 2024
But by leveraging digital tools, pharma can help them find and access specialist care early in their journey. Treatment delays can seriously impact patients’ health outcomes.
139 Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
US Senate committee interrogates big pharma on “outrageously high” drug prices
Pharmaceutical Technology
FEBRUARY 9, 2024
Pharma CEOs defended their high prescription drug costs, stating that the current prices are necessary for continued innovation.
Drugs 282
282 Drugs 282
282 
Redx Pharma gets grant for ROCK inhibitors for treating ROCK mediated diseases
Pharmaceutical Technology
APRIL 23, 2024
Discover Redx Pharma's groundbreaking patent for novel compounds targeting ROCK1 and ROCK2 inhibitors. Explore the unique structural features and therapeutic potential of these compounds in treating ROCK mediated diseases.
130 
Boehringer Ingelheim acquires T3 Pharma for $509m
Pharmaceutical Technology
NOVEMBER 23, 2023
T3 Pharma uses a bacterial secretion system for the delivery of immune-modulating proteins to cancer cells and tumour micro-environments.
Protein 242
242 Protein 242
242 
Pharma benefited from basing business overseas. An international tax effort could spur a rethink.
Bio Pharma Dive
NOVEMBER 28, 2023
tax law changes enacted six years ago slashed large pharma companies' rates and saved them billions. Now, a push for an international floor could disrupt their R&D accounting.
Pharma Companies 300
300 Pharma Companies 300
300 
Otsuka Pharmaceutical agrees to buy Mindset Pharma
Pharmaceutical Technology
SEPTEMBER 1, 2023
Otsuka Pharmaceutical has signed a definitive arrangement agreement to acquire Mindset Pharma, in an all-cash deal worth C$80m ($59.1m).
263 
Purdue Pharma gets grant for treatment of T-cell prolymphocytic leukemia using tinostamustine
Pharmaceutical Technology
APRIL 22, 2024
Discover the groundbreaking patent by Purdue Pharma for treating T-cell prolymphocytic leukemia with tinostamustine. Learn about the innovative kit and dosage guidelines for effective T-PLL treatment.
130 
Jardiance and Ofev propel Boehringer’s human pharma sales
Pharmaceutical Technology
APRIL 16, 2024
Boehringer Ingelheim announced consistent growth across its human pharma sales and R&D investments in 2023.
Sales 130
130 Sales 130
130 
Sun Pharma initiates recall of Febuxostat for gout in US
Pharmaceutical Technology
MARCH 11, 2024
Sun Pharma has announced a recall of 55,000 bottles of Febuxostat, a medication used to treat gout, from the US market
Marketing 200
200 Marketing 200
200 
LGM Pharma announces advanced analytical services
Pharmaceutical Technology
MARCH 14, 2024
Contract development and manufacturing organisation LGM Pharma has announced the advancement of its analytical testing services.
Manufacturing 130
130 
Jacobio Pharma receives breakthrough therapy designation for glecirasib
Pharmaceutical Technology
AUGUST 8, 2023
Jacobio Pharma received breakthrough therapy designation (BTD) for glecirasib to treat pancreatic cancer patients with the KRAS G12C mutation.
246 
Rigosertib sodium by Traws Pharma for Epidermolysis Bullosa: Likelihood of Approval
Pharmaceutical Technology
APRIL 18, 2024
Rigosertib sodium is under clinical development by Traws Pharma and currently in Phase II for Epidermolysis Bullosa.
What pharma stands to gain from technological innovation
pharmaphorum
APRIL 22, 2024
Explore the potential advantages for the pharma industry. Pharmaceutical companies stand to gain significant benefits from technological innovation in the form of improved data analytics, streamlined healthcare processes, and enhanced patient outcomes.
113 
Cybersecurity in pharma: Securing the future
Pharmaceutical Technology
JUNE 5, 2023
Pharma companies around the world have also faced similar threats , some of which have impacted national security and public health. Future outlook Kim is hopeful that cybersecurity in the pharma industry will benefit from increased automation. Our defences can be much more agile than they are today.
Compliance 276
276 
What to look for when hiring in pharma
World of DTC Marketing
AUGUST 15, 2022
The great resignation has not affected pharma because the jobs within the industry pay very well and most positions and employees like the benefit of having a steady job with good money. However, some pharma companies are having problems filling open positions, and when they do, they often find it wasn’t a good fit.
Pharma Companies 281
281 
Innate Pharma plans IND of ADC candidate after positive preclinical data
Pharmaceutical Technology
APRIL 10, 2024
Innate Pharma plans to advance IPH45 towards clinical trials, with an investigational new drug (IND) application planned in 2024.
Clinical Trials 130
130 
Rx Machina: How AI is transforming pharma sales
Pharmaceutical Technology
JULY 31, 2023
Pharma sales have undergone a seismic transformation after Covid-19, with the adoption of artificial intelligence tools.
Sales 246
246 Sales 246
246 
Redx Pharma gets grant for ROCK inhibitors for treating ROCK mediated diseases
Pharmaceutical Technology
APRIL 1, 2024
Discover Redx Pharma's groundbreaking patent for novel compounds targeting ROCK1 and ROCK2 inhibitors. Learn about the formula, structural features, and pharmaceutical applications covered in this exclusive patent.
130 
Reuters Pharma USA 2024 – Serena Goodwin
pharmaphorum
APRIL 19, 2024
Stay updated on the latest STEM Healthcare news from Reuters Pharma USA 2024, featuring insights from global account lead at STEM, Serena Goodwin on the impact of AI in healthcare.
97 
Acceleron Pharma gets grant for treatment of spinal muscular atrophy using ALK4:ACTIRiib antagonists
Pharmaceutical Technology
APRIL 10, 2024
Discover how Acceleron Pharma's patent for treating spinal muscular atrophy with ALK4:ActRIIB antagonists aims to increase muscle mass, strength, and bone density in patients.
130 
Conference report: Reuters Pharma USA
pharmaphorum
APRIL 4, 2024
Last week, pharmaphorum editor-in-chief Jonah Comstock travelled to Philadelphia for Reuters Pharma USA. On today’s podcast, he chats with guest host and Deep Dive editor Eloise McLellan about his biggest takeaways from the two-day event.
111 
DoP releases new UCPMP for pharma and medical devices companies
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 17, 2024
The Department of Pharmaceuticals (DoP) has issued a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, permitting pharma companies to provide brand reminders such as informational and education items and free samples to medical professionals with restrictions on sample packs and total value.
Pharma Companies 156
156 
Reuters Pharma Europe 2024 – Day Three
pharmaphorum
APRIL 17, 2024
As Reuters Pharma Europe 2024 comes to a close in Barcelona, pharmaphorum remains on site to live blog the last remaining talks and insights.
104 
Changing Faces: Pharma and biotech hires from March 2024
pharmaphorum
APRIL 8, 2024
Stay up to date with the latest pharma and biotech hires from March 2024, including notable companies like Sitryx, Oxford, and MaaT Pharma.
115 
Reuters Pharma USA 2024 - Day 2
pharmaphorum
MARCH 27, 2024
Get live coverage of the latest updates and developments from Day 2 of Reuters Pharma USA 2024. Stay informed with real-time news and insights from the event.
Development 113
113 Development 113
113 
Selkirk Pharma: Adapting to regulatory shifts and market demand
BioPharma Reporter
APRIL 22, 2024
Ahead of CPHI North America, we caught up with Lisa Stiles, director, business development at Selkirk Pharma, an exhibitor at the event, to find out how the CMO is navigating regulatory changes, challenges and more.
Marketing 98
98 
Reuters Pharma USA 2024 - Day 1
pharmaphorum
MARCH 26, 2024
Get live coverage of the latest updates and developments from Day 1 of Reuters Pharma USA 2024. Stay informed with real-time news and insights from the event.
Development 114
114 Development 114
114 
EU pharma reform package clears key Parliament vote
pharmaphorum
APRIL 11, 2024
The European Parliament has voted through reforms to legislation regulating the pharma sector, which the industry claims could compromise competitiveness and patient care.
Packaging 105
105 
Monlunabant by Inversago Pharma for Obesity: Likelihood of Approval
Pharmaceutical Technology
APRIL 17, 2024
Monlunabant is under clinical development by Inversago Pharma and currently in Phase II for Obesity.
Monlunabant by Inversago Pharma for Metabolic Syndrome: Likelihood of Approval
Pharmaceutical Technology
APRIL 17, 2024
Monlunabant is under clinical development by Inversago Pharma and currently in Phase II for Metabolic Syndrome.
Rigosertib sodium by Traws Pharma for Epidermolysis Bullosa: Likelihood of Approval
Pharmaceutical Technology
APRIL 18, 2024
Rigosertib sodium is under clinical development by Traws Pharma and currently in Phase II for Epidermolysis Bullosa.
The rise of the new pharma marketer in an evolving commercial model
Bio Pharma Dive
AUGUST 14, 2023
Meet the pharma marketer of the future, primed for personalization and powered by technology.
Marketing 246
246 Marketing 246
246 
The rise of the new pharma marketer in an evolving commercial model
Bio Pharma Dive
JULY 17, 2023
Meet the pharma marketer of the future, primed for personalization and powered by technology.
Marketing 246
246 Marketing 246
246 
Bormioli Pharma leading the way with sustainable pharmaceutical packaging
Outsourcing Pharma
APRIL 17, 2024
Bormioli Pharma creates pharmaceutical packaging for drug stability, safety, and sustainability, partnering with global health leaders and says it stands at the forefront of sustainability.
Packaging 86
86 
'The Top Line': A look at pharma revenue rankings
Fierce Pharma
APRIL 25, 2024
Fierce Pharma publishes a yearly special report highlighting the top 20 pharmas based on their revenue. This week on "The Top Line," Fierce Pharma Senior Editor Eric Sagonowsky and Staff Writer Kevin Dunleavy are diving into our annual top pharma companies by revenue special report.
Madrigal Pharma is first over the MASH finish line
pharmaphorum
MARCH 15, 2024
Madrigal Pharma is first pharma company to get FDA approval for a drug to treat metabolic dysfunction-associated steatohepatitis (MASH)
FDA Approval 105
105 
Reuters Pharma USA 2024 – Meruno Perugini
pharmaphorum
APRIL 26, 2024
Merino Perugini from Nestlé Health Science sat down for an exclusive interview with Jonah Comstock from Reuters Pharma USA to discuss the company's latest innovations and successes in the healthcare industry. Get insights into their strategies and future plans.
52 
Using AI to Become Pharma's Next Superhero
Fierce Pharma
NOVEMBER 20, 2023
“AI is becoming part of the pharma fabric, and it really is set to disrupt the industry.” | Viz.ai’s Nina Binetti is joined by colleagues at CrowdPharm and Remedy Product Studio to explore the various ways in which AI is being used among pharma companies – from improving patient diagnoses and treatments to unlocking operating efficiencies.
Pharma Companies 120
120 
Changing Faces: Pharma and biotech hires from February 2024
pharmaphorum
MARCH 11, 2024
Stay updated with the latest pharma and biotech hires from February 2024 at companies like AbbVie, Astellas, EnteroBiotix, and Resalis Therapeutics in Changing Faces.
113 
EU pharma legislation reforms inch closer to fruition
pharmaphorum
MARCH 20, 2024
EU pharma legislation gets closer to fruition as European Parliament's ENVI committee votes in favour of amendments, but industry remains concerned
105 
Recent pharma industry appointments that should be on your radar - KBI Biopharma, Veranova and more
BioPharma Reporter
APRIL 11, 2024
Bio Pharma Reporter and Outsourcing Pharma is back with our latest instalment of movers and shakers - breaking down all the key pharma industry appointments that you should know about. KBI Biopharma, Veranova and Kindeva Drug Delivery are among the companies welcoming new faces to top jobs.
AI could revolutionise pharma compound synthesis
pharmaphorum
JANUARY 15, 2024
Researchers at the University of Cambridge and Pfizer have developed an AI-powered approach to make it easier to design and make pharma molecules
Development 118
118 
Navigating digital transformation in pharma: The rise of mobile messaging
pharmaphorum
MARCH 15, 2024
However, like any software, they still have potential cybersecurity risks and compliance concerns that users should be aware of - especially in pharma. Popular mobile messaging apps that offer end-to-end encryption for their users' communications means that the content of messages is only accessible to the sender and the recipient.
Compliance 124
124 Compliance 124
124 
Let's personalize your content